Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 229993, "name": "Neuland Labs.", "stock_name": "Neuland Labs.", "full_name": "Neuland Laboratories Ltd", "name_url": "stocks-analysis/neuland-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "18,916.45", "chg": -65.85, "chgp": "-0.35%", "dir": -1, "prev_price": "18,982.30", "mcapval": "24,181.00 Cr", "mcap": "Small Cap", "scripcode": 524558, "symbol": "NEULANDLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE794A01010", "curr_date": "Jul 03, 03:30 PM", "curr_time": "16:23 PM", "last_traded_at": "Jul 03, 03:30 PM IST", "bse_nse_vol": "96.98 k", "exc_status": "Active", "traded_date": "Jul 03, 2026", "traded_date_str": "2026 07 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Neuland Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4089540", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NeulandLaborato_mojoScore_4089540.png", "date": "2026-07-05 10:10:05", "description": "Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Neuland Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4070405", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_mojoScore_4070405.png", "date": "2026-06-24 10:10:04", "description": "Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Neuland Laboratories Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4069501", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4069501.png", "date": "2026-06-24 08:00:44", "description": "Neuland Laboratories Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators that suggest a strengthening uptrend. The stock’s recent performance, coupled with upgraded technical grades and a robust Mojo Score, positions it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4054836", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4054836.png", "date": "2026-06-16 08:01:05", "description": "Neuland Laboratories Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early June 2026. Despite a slight dip in daily price, key technical indicators such as MACD, RSI, and moving averages reveal a complex interplay of signals that investors should carefully analyse amid the broader Pharmaceuticals & Biotechnology sector dynamics." }, { "title": "Neuland Laboratories Ltd Declines 1.49%: 4 Key Technical and Fundamental Factors This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-declines-149-4-key-technical-and-fundamental-factors-this-week-4053110", "imagepath": "", "date": "2026-06-14 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Golden Cross formation signalling potential bullish breakout</p>\n <p><strong>2 June:</strong> Upgrade to Buy rating by MarketsMOJO on strong financials and technicals</p>\n <p><strong>2 June:</strong> Strong technical momentum confirmed amid bullish shift</p>\n <p><strong>3 June:</strong> Technical momentum shifts to mildly bullish with price consolidation</p>\n <p><strong>5 June:</strong> Week closes at Rs.16,812.90 (-1.49%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-va..." }, { "title": "Neuland Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4051088", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_mojoScore_4051088.png", "date": "2026-06-13 10:10:05", "description": "Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 June 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4043167", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4043167.png", "date": "2026-06-10 08:00:56", "description": "Neuland Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, suggesting a strengthening price momentum amid a positive market backdrop for the pharmaceuticals and biotechnology sector." }, { "title": "Neuland Laboratories Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4032704", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4032704.png", "date": "2026-06-03 08:00:42", "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from bullish to mildly bullish trends. Despite a slight dip in the daily price, the stock’s medium- and long-term indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook." }, { "title": "Neuland Laboratories Upgraded to Buy on Strong Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4030038", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_mojoScore_4030038.png", "date": "2026-06-02 08:17:27", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 June 2026, comes amid robust quarterly results, sustained long-term growth, and a shift to bullish technical momentum, positioning the small-cap pharmaceutical firm favourably against market benchmarks." } ], "total": 781, "sid": "229993", "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "02-Jul-2026", "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "25-Jun-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "16-Jun-2026", "details": "Copy of Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has declared <strong>340%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14", "dt": "2014-08-13", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

1 June: Golden Cross formation signalling potential bullish breakout

2 June: Upgrade to Buy rating by MarketsMOJO on strong financials and technicals

2 June: Strong technical momentum confirmed amid bullish shift

3 June: Technical momentum shifts to mildly bullish with price consolidation

5 June: Week closes at Rs.16,812.90 (-1.49%)

Week Open

Read full news article

Neuland Laboratories Ltd is Rated Buy

2026-06-13 10:10:05

Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Neuland Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-10 08:00:56

Neuland Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, suggesting a strengthening price momentum amid a positive market backdrop for the pharmaceuticals and biotechnology sector.

Read full news article

Neuland Laboratories Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-06-03 08:00:42

Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from bullish to mildly bullish trends. Despite a slight dip in the daily price, the stock’s medium- and long-term indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook.

Read full news article

Neuland Laboratories Upgraded to Buy on Strong Financials and Bullish Technicals

2026-06-02 08:17:27

Neuland Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 June 2026, comes amid robust quarterly results, sustained long-term growth, and a shift to bullish technical momentum, positioning the small-cap pharmaceutical firm favourably against market benchmarks.

Read full news article